Veterinary Medicines

ORIDERMYL, mast za uho, za pse i mačke

Authorised
  • Permethrin
  • NEOMYCIN SULPHATE PH. EUR.
  • Nystatin
  • Triamcinolone acetonide
Download as PDF

Product identification

Medicine name:
ORIDERMYL, mast za uho, za pse i mačke
Active substance:
  • Permethrin
  • NEOMYCIN SULPHATE PH. EUR.
  • Nystatin
  • Triamcinolone acetonide
Target species:
  • Dog
  • Cat
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • Permethrin
    10.00
    milligram(s)
    /
    1.00
    gram(s)
  • NEOMYCIN SULPHATE PH. EUR.
    3500.00
    international unit(s)
    /
    1.00
    gram(s)
  • Nystatin
    100000.00
    international unit(s)
    /
    1.00
    gram(s)
  • Triamcinolone acetonide
    1.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Ear ointment
Withdrawal period by route of administration:
  • Auricular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02CA04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/18-01/327
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 21/06/2023
Updated on: 26/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."